Trial Profile
A 120-day bridging study to evaluate the effects of LODONAL in cancer patients
Status:
Planning
Phase of Trial:
Phase II/III
Latest Information Update: 22 Jun 2023
Price :
$35
*
At a glance
- Drugs Naltrexone (Primary)
- Indications Cancer
- Focus Therapeutic Use
- 06 Aug 2015 New trial record